“There’s a lot of lower-level head trauma out there that no one knows the consequence of,” says John Q. Trojanowski of PARC in a New York Times article. Trojanowski plans to submit a research paper in the coming months on people who have suffered traumatic brain injury. “We are looking at people with traumatic brain injury, football players, rugby players, some people who fell off bikes.”
John Q. Trojanowski's research on tau becomes toxic and spreads from cell to cell in diseasesd brains is discussed in a recent Penn Medicine press release: "Penn Medicine Receives $1.45 Million to Speed Research for Rare Neurodegenerative Diseases: CurePSP to Partner with Penn Medicine to Raise Additional Funds."
After several years of incremental study, researchers at the Perelman School of Medicine, including John Q. Trojanowski, have been able to piece together important steps in how Parkinson’s disease (PD) spreads from cell to cell and leads to nerve cell death.
A new study co-authored by experts from the Perelman School of Medicine, including John Q. Trojanowski, has found a group of biomarkers that hold up in statistical analyses in three independent groups of Alzheimer's patients.
Trojanowski and colleagues are mentioned in a news article on "Biomarkers in Blood May Detect Alzheimer's Disease and Mild Cognitive Impairment: Penn Study Promising First Step toward Blood Test for Alzheimer's."
Trojanowski and colleagues finds that Anti-Tau Drug Improves Cognition and Decreases Tau Tangles in Alzheimer's Disease Models and Drugmaker Begins Phase I Clinical Trial to Test Microtubule Stabilizing-Drug in Mild Alzheimer's Cases.